This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur De Lille, National Institute of Health and Medical Research. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2012
Title: Benoît Deprez: Innovator in Antibiotic Potentiation
Introduction
Benoît Deprez is a notable inventor based in Lille, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance the efficacy of antibiotics. His work is crucial in the fight against mycobacterial infections, including tuberculosis and leprosy.
Latest Patents
Benoît Deprez holds a patent titled "Compounds having a potentiating effect on the activity of ethionamide and uses thereof." This invention focuses on the use of compounds that enhance the activity of antibiotics that are activatable via the EthA enzymatic pathway. The patent outlines the preparation of medicaments aimed at preventing and treating mycobacterial infections. It also details pharmaceutical compositions that combine these compounds with antibiotics, emphasizing their potential in medical applications.
Career Highlights
Throughout his career, Benoît Deprez has worked with prestigious institutions such as the Institut Pasteur de Lille and the Centre National de la Recherche Scientifique. His research has been instrumental in advancing the understanding of antibiotic resistance and improving treatment options for serious infections.
Collaborations
Benoît has collaborated with notable colleagues, including Nicolas Willand and Bertrand Dirie. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Benoît Deprez's work exemplifies the importance of innovation in the pharmaceutical industry. His contributions to antibiotic potentiation are vital in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile